Observational studyPediatric pulmonology2020

Long-term effects of ivacaftor on nonpulmonary outcomes in individuals with cystic fibrosis, heterozygous for a S1251N mutation.

M Marcella Burghard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.